{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:46:12Z","timestamp":1789962372249,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-024-02345-9","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T03:01:30Z","timestamp":1710298890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients: a single-center experience in Japan"],"prefix":"10.1007","volume":"47","author":[{"given":"Tatsuki","family":"Mochizuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0323-6628","authenticated-orcid":false,"given":"Bikei","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Kamijyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamon","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Kushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitsugu","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takakazu","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"2345_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2023.10.003","author":"Y Akamatsu","year":"2023","unstructured":"Akamatsu Y, Chida K, Miyoshi K, Kojima D, Nomura J-I, Setta K, Chiba T, Koji T, Fujiwara S, Kashimura H, Kubo Y, Ogasawara K (2023) Fluid balance management with loop diuretics in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a case series. Brain Hemorrhages. https:\/\/doi.org\/10.1016\/j.hest.2023.10.003","journal-title":"Brain Hemorrhages"},{"key":"2345_CR2","doi-asserted-by":"publisher","unstructured":"Barker FG 2nd, Ogilvy CS (1996) Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84:405\u2013414. https:\/\/doi.org\/10.3171\/jns.1996.84.3.0405","DOI":"10.3171\/jns.1996.84.3.0405"},{"key":"2345_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fneur.2014.00072","volume":"5","author":"AM Bauer","year":"2014","unstructured":"Bauer AM, Rasmussen PA (2014) Treatment of intracranial vasospasm following subarachnoid hemorrhage. Front Neurol 5:72. https:\/\/doi.org\/10.3389\/fneur.2014.00072","journal-title":"Front Neurol"},{"key":"2345_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/neurosurgery\/46.1.28","volume":"46","author":"VL Chiang","year":"2000","unstructured":"Chiang VL, Claus EB, Awad IA (2000) Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage. Neurosurgery 46:28\u201335 discussion 35\u2009\u2013\u200926","journal-title":"Neurosurgery"},{"key":"2345_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1124\/pr.115.011833","volume":"68","author":"AP Davenport","year":"2016","unstructured":"Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ (2016) Endothelin Pharmacol Rev 68:357\u2013418. https:\/\/doi.org\/10.1124\/pr.115.011833","journal-title":"Endothelin Pharmacol Rev"},{"key":"2345_CR6","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3171\/2022.2.Jns212914","volume":"137","author":"H Endo","year":"2022","unstructured":"Endo H, Hagihara Y, Kimura N, Takizawa K, Niizuma K, Togo O, Tominaga T (2022) Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg 137:1707\u20131717. https:\/\/doi.org\/10.3171\/2022.2.Jns212914","journal-title":"J Neurosurg"},{"key":"2345_CR7","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/jcbfm.2011.7","volume":"31","author":"N Etminan","year":"2011","unstructured":"Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 31:1443\u20131451. https:\/\/doi.org\/10.1038\/jcbfm.2011.7","journal-title":"J Cereb Blood Flow Metab"},{"key":"2345_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13054-016-1447-6","volume":"20","author":"CL Francoeur","year":"2016","unstructured":"Francoeur CL, Mayer SA (2016) Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care 20:277. https:\/\/doi.org\/10.1186\/s13054-016-1447-6","journal-title":"Crit Care"},{"key":"2345_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000475824","volume":"44","author":"M Fujimura","year":"2017","unstructured":"Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T (2017) Preventive effect of Clazosentan against Cerebral Vasospasm after clipping surgery for Aneurysmal Subarachnoid hemorrhage in Japanese and Korean patients. Cerebrovasc Dis 44:59\u201367. https:\/\/doi.org\/10.1159\/000475824","journal-title":"Cerebrovasc Dis"},{"key":"2345_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12028-013-9860-z","volume":"19","author":"GM Ibrahim","year":"2013","unstructured":"Ibrahim GM, Macdonald RL (2013) The effects of fluid balance and colloid administration on outcomes in patients with aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis. Neurocrit Care 19:140\u2013149. https:\/\/doi.org\/10.1007\/s12028-013-9860-z","journal-title":"Neurocrit Care"},{"key":"2345_CR11","doi-asserted-by":"publisher","first-page":"e0230953","DOI":"10.1371\/journal.pone.0230953","volume":"15","author":"K Ido","year":"2020","unstructured":"Ido K, Kurogi R, Kurogi A, Nishimura K, Arimura K, Nishimura A, Ren N, Kada A, Matsuo R, Onozuka D, Hagihara A, Takagishi S, Yamagami K, Takegami M, Nohara Y, Nakashima N, Kamouchi M, Date I, Kitazono T, Iihara K (2020) Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. PLoS ONE 15:e0230953. https:\/\/doi.org\/10.1371\/journal.pone.0230953","journal-title":"PLoS ONE"},{"key":"2345_CR12","first-page":"171","volume-title":"Guideline 2021 for the treatment of stroke [Revised version 2023]","author":"Japan Stroke Society","year":"2023","unstructured":"Japan Stroke Society (2023) Guideline 2021 for the treatment of stroke [Revised version 2023]. In. KYOWA KIKAKU, Tokyo, p 171"},{"key":"2345_CR13","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/01.Wcb.0000125886.48838.7e","volume":"24","author":"G Kusaka","year":"2004","unstructured":"Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH (2004) Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 24:916\u2013925. https:\/\/doi.org\/10.1097\/01.Wcb.0000125886.48838.7e","journal-title":"J Cereb Blood Flow Metab"},{"key":"2345_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/01.str.31.2.383","volume":"31","author":"L Lennihan","year":"2000","unstructured":"Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA (2000) Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 31:383\u2013391. https:\/\/doi.org\/10.1161\/01.str.31.2.383","journal-title":"Stroke"},{"key":"2345_CR15","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1161\/strokeaha.108.519942","volume":"39","author":"RL Macdonald","year":"2008","unstructured":"Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A (2008) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39:3015\u20133021. https:\/\/doi.org\/10.1161\/strokeaha.108.519942","journal-title":"Stroke"},{"key":"2345_CR16","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1161\/strokeaha.111.648980","volume":"43","author":"RL Macdonald","year":"2012","unstructured":"Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Nowbakht P, Roux S, Kassell N (2012) Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 43:1463\u20131469. https:\/\/doi.org\/10.1161\/strokeaha.111.648980","journal-title":"Stroke"},{"key":"2345_CR17","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.wnsx.2023.100253","volume":"21","author":"T Maeda","year":"2024","unstructured":"Maeda T, Okawara M, Osakabe M, Yamaguchi H, Maeda T, Kurita H (2024) Initial real-world experience of clazosentan for subarachnoid hemorrhage in Japan. World Neurosurg X 21:100253. https:\/\/doi.org\/10.1016\/j.wnsx.2023.100253","journal-title":"World Neurosurg X"},{"key":"2345_CR18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1080\/14656566.2021.1912013","volume":"22","author":"T Maruhashi","year":"2021","unstructured":"Maruhashi T, Higashi Y (2021) An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage. Expert Opin Pharmacother 22:1601\u20131614. https:\/\/doi.org\/10.1080\/14656566.2021.1912013","journal-title":"Expert Opin Pharmacother"},{"key":"2345_CR19","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/17474930221090347","volume":"17","author":"S Miyamoto","year":"2022","unstructured":"Miyamoto S, Ogasawara K, Kuroda S, Itabashi R, Toyoda K, Itoh Y, Iguchi Y, Shiokawa Y, Takagi Y, Ohtsuki T, Kinouchi H, Okada Y, Takahashi JC, Nakase H, Kakuda W (2022) Japan Stroke Society Guideline 2021 for the treatment of stroke. Int J Stroke 17:1039\u20131049. https:\/\/doi.org\/10.1177\/17474930221090347","journal-title":"Int J Stroke"},{"key":"2345_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1053\/jscd.2002.130390","volume":"11","author":"A Molyneux","year":"2002","unstructured":"Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R (2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. J Stroke Cerebrovasc Dis 11:304\u2013314. https:\/\/doi.org\/10.1053\/jscd.2002.130390","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2345_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10143-023-02104-2","volume":"46","author":"S Muraoka","year":"2023","unstructured":"Muraoka S, Asai T, Fukui T, Ota S, Shimato S, Koketsu N, Nishizawa T, Araki Y, Saito R (2023) Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study. Neurosurg Rev 46:195. https:\/\/doi.org\/10.1007\/s10143-023-02104-2","journal-title":"Neurosurg Rev"},{"key":"2345_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s1474-4422(09)70126-7","volume":"8","author":"DJ Nieuwkamp","year":"2009","unstructured":"Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635\u2013642. https:\/\/doi.org\/10.1016\/s1474-4422(09)70126-7","journal-title":"Lancet Neurol"},{"key":"2345_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2023.11.007","author":"R Nishii","year":"2023","unstructured":"Nishii R, Ohta T, Fukui N, Koyanagi M, Goto M, Takeda J, Fukumitsu R, Sunohara T, Takano Y, Teranishi K, Nakajima K, Naramoto Y, Yamamoto Y, Kawade S, Sakisuka R, Takamatsu T, Tokuda M, Tomita H, Yoshimoto M, Sakai N (2023) A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage. Brain Hemorrhages. https:\/\/doi.org\/10.1016\/j.hest.2023.11.007","journal-title":"Brain Hemorrhages"},{"key":"2345_CR24","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1007\/s12035-018-1213-7","volume":"56","author":"T Peeyush Kumar","year":"2019","unstructured":"Peeyush Kumar T, McBride DW, Dash PK, Matsumura K, Rubi A, Blackburn SL (2019) Endothelial cell dysfunction and Injury in Subarachnoid Hemorrhage. Mol Neurobiol 56:1992\u20132006. https:\/\/doi.org\/10.1007\/s12035-018-1213-7","journal-title":"Mol Neurobiol"},{"key":"2345_CR25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3171\/jns.1988.68.6.0985","volume":"68","author":"Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale","year":"1988","unstructured":"Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale (1988) J Neurosurg 68:985\u2013986. https:\/\/doi.org\/10.3171\/jns.1988.68.6.0985","journal-title":"J Neurosurg"},{"key":"2345_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13613-016-0128-6","volume":"6","author":"Y Sakr","year":"2016","unstructured":"Sakr Y, D\u00fcnisch P, Santos C, Matthes L, Zeidan M, Reinhart K, Kalff R, Ewald C (2016) Poor outcome is associated with less negative fluid balance in patients with aneurysmal subarachnoid hemorrhage treated with prophylactic vasopressor-induced hypertension. Ann Intensive Care 6:25. https:\/\/doi.org\/10.1186\/s13613-016-0128-6","journal-title":"Ann Intensive Care"},{"key":"2345_CR27","doi-asserted-by":"publisher","unstructured":"Shirao S, Yoneda H, Ishihara H, Kajiwara K, Suzuki M (2011) A proposed definition of symptomatic vasospasm based on treatment of cerebral vasospasm after subarachnoid hemorrhage in Japan: Consensus 2009, a project of the 25 Spasm Symposium. Surg Neurol Int 2:74. https:\/\/doi.org\/10.4103\/2152-7806.81968","DOI":"10.4103\/2152-7806.81968"},{"key":"2345_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1227\/00006123-198812000-00002","volume":"23","author":"RA Solomon","year":"1988","unstructured":"Solomon RA, Fink ME, Lennihan L (1988) Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery 23:699\u2013704. https:\/\/doi.org\/10.1227\/00006123-198812000-00002","journal-title":"Neurosurgery"},{"key":"2345_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/HCO.0b013e328302f3c6","volume":"23","author":"BL Stauffer","year":"2008","unstructured":"Stauffer BL, Westby CM, DeSouza CA (2008) Endothelin-1, aging and hypertension. Curr Opin Cardiol 23:350\u2013355. https:\/\/doi.org\/10.1097\/HCO.0b013e328302f3c6","journal-title":"Curr Opin Cardiol"},{"key":"2345_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamaneurol.2015.3188","volume":"73","author":"S Suwatcharangkoon","year":"2016","unstructured":"Suwatcharangkoon S, Meyers E, Falo C, Schmidt JM, Agarwal S, Claassen J, Mayer SA (2016) Loss of consciousness at Onset of Subarachnoid Hemorrhage as an important marker of Early Brain Injury. JAMA Neurol 73:28\u201335. https:\/\/doi.org\/10.1001\/jamaneurol.2015.3188","journal-title":"JAMA Neurol"},{"key":"2345_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.surneu.2006.10.037","volume":"68","author":"Y Suzuki","year":"2007","unstructured":"Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K (2007) A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage. Surg Neurol 68:126\u2013131 discussion 131\u2009\u2013\u2009122. https:\/\/doi.org\/10.1016\/j.surneu.2006.10.037","journal-title":"Surg Neurol"},{"key":"2345_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14670\/hh-18-253","volume":"36","author":"H Suzuki","year":"2021","unstructured":"Suzuki H, Kanamaru H, Kawakita F, Asada R, Fujimoto M, Shiba M (2021) Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Histol Histopathol 36:143\u2013158. https:\/\/doi.org\/10.14670\/hh-18-253","journal-title":"Histol Histopathol"},{"key":"2345_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.hest.2023.10.006","author":"H Suzuki","year":"2023","unstructured":"Suzuki H, Nakajima H, Ichikawa T, Yasuda R, Okada T, Goto F, Ito S, Horiuchi Y, Kitano Y, Nishikawa H, Fujimoto M, Toma N (2023) Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage. Brain Hemorrhages. https:\/\/doi.org\/10.1016\/j.hest.2023.10.006","journal-title":"Brain Hemorrhages"},{"key":"2345_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.25259\/sni_551_2019","volume":"11","author":"S Takahashi","year":"2020","unstructured":"Takahashi S, Akiyama T, Horiguchi T, Miwa T, Takemura R, Yoshida K (2020) Loss of consciousness at ictus and\/or poor World Federation of Neurosurgical Societies grade on admission reflects the impact of EBI and predicts poor outcome in patients with SAH. Surg Neurol Int 11:40. https:\/\/doi.org\/10.25259\/sni_551_2019","journal-title":"Surg Neurol Int"},{"key":"2345_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0090-3019(91)90228-2","volume":"36","author":"K Tokiyoshi","year":"1991","unstructured":"Tokiyoshi K, Ohnishi T, Nii Y (1991) Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage. Surg Neurol 36:112\u2013118. https:\/\/doi.org\/10.1016\/0090-3019(91)90228-2","journal-title":"Surg Neurol"},{"key":"2345_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3892\/mi.2022.59","volume":"2","author":"V Tsolaki","year":"2022","unstructured":"Tsolaki V, Aravantinou-Fatorou A, Georgakopoulou VE, Spandidos DA, Papalexis P, Mathioudakis N, Tarantinos K, Trakas N, Sklapani P, Fotakopoulos G (2022) Early diagnosis of cerebral vasospasm associated with cerebral ischemia following subarachnoid hemorrhage: evaluation of computed tomography perfusion and transcranial doppler as accurate methods. Med Int (Lond) 2:34. https:\/\/doi.org\/10.3892\/mi.2022.59","journal-title":"Med Int (Lond)"},{"key":"2345_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3171\/jns.2005.103.1.0009","volume":"103","author":"P Vajkoczy","year":"2005","unstructured":"Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, Breu V, Schmiedek P (2005) Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 103:9\u201317. https:\/\/doi.org\/10.3171\/jns.2005.103.1.0009","journal-title":"J Neurosurg"},{"key":"2345_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1124\/jpet.116.234930","volume":"361","author":"M Vercauteren","year":"2017","unstructured":"Vercauteren M, Trensz F, Pasquali A, Cattaneo C, Strasser DS, Hess P, Iglarz M, Clozel M (2017) Endothelin ET(A) receptor blockade, by activating ET(B) receptors, increases vascular permeability and induces Exaggerated Fluid Retention. J Pharmacol Exp Ther 361:322\u2013333. https:\/\/doi.org\/10.1124\/jpet.116.234930","journal-title":"J Pharmacol Exp Ther"},{"key":"2345_CR39","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s11357-020-00309-7","volume":"43","author":"AP Young","year":"2021","unstructured":"Young AP, Zhu J, Bagher AM, Denovan-Wright EM, Howlett SE, Kelly MEM (2021) Endothelin B receptor dysfunction mediates elevated myogenic tone in cerebral arteries from aged male Fischer 344 rats. GeroScience 43:1447\u20131463. https:\/\/doi.org\/10.1007\/s11357-020-00309-7","journal-title":"GeroScience"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-02345-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-024-02345-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-02345-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:28:26Z","timestamp":1741084106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-024-02345-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2345"],"URL":"https:\/\/doi.org\/10.1007\/s10143-024-02345-9","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"29 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Ryu, Dr. Mochizuki, and Dr. Sato report lecture fees from Idorsia outside the scope of the submitted work. The other authors declare no financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures involving human participants conducted in this study were according to the ethical standards of the Institutional and National Research Committee (Saint Luke\u2019s International Hospital, No.23-R031) and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participants consented to the submission of the article to the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"113"}}